appendicitis
Appendicitis refers to inflammatory changes in the appendix due to various factors. It is a common disease, and its prognosis depends on whether it is diagnosed and treated in time. With early diagnosis and treatment, most patients can recover in a short period of time, and the mortality rate is extremely low (0.1%-0.2%); if the diagnosis and treatment are delayed, it can cause serious complications and even death. Appendicitis is a common disease. Clinically, there are often symptoms such as right lower abdominal pain, fever, vomiting, and neutrophilia. Appendicitis is an inflammation of the appendix, the most common abdominal surgical disease.
-
Site of disease:
appendix -
Infectious :
Not contagious -
Frequent population:
Young people -
Related symptoms:
Stomach ache right lower abdominal pain nausea and vomiting loss of appetite nausea -
Concurrent disease:
Related Drugs
Appendicitis anti-inflammatory tablets
Manufacturer:
Guangdong Xiantong Pharmaceutical Co., Ltd.
Zhongjiefeng injection
Manufacturer:
Tonghua Huaxia Pharmaceutical Co., Ltd.
Zhongjiefeng injection
Manufacturer:
Fujian Gutian Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:
Hainan Hailing Chemipharma Corporation Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for the following moderate to severe infections caused by B-lactamase-producing bacteria that are resistant to piperacillin sodium but sensitive to piperacillin/tazobactam: 1. Appendicitis (accompanied by perforation or abscess) and appendicitis caused by piperacillin- and B-lactamase-resistant Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides polyspermum or Bacteroides vulgaris). 2. Skin and soft tissue infections caused by piperacillin- and B-lactamase-resistant Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin- and B-lactamase-resistant Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin- and B-lactamase-resistant Haemophilus influenzae. 5.
Qingrexiaoyanning capsule
Manufacturer:
Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd.
Qingrexiaoyanning capsule
Manufacturer:
Wuhushan Pharmaceutical Co., Ltd.
Imipenem and Cilastatin Sodium for Injection
Indication: This product is a very broad-spectrum antibiotic, especially suitable for mixed infections caused by multiple pathogens, and early treatment before the pathogen is identified. This product is suitable for the following infections caused by sensitive bacteria: intra-abdominal infection, lower respiratory tract infection, gynecological infection, urogenital tract infection, bone and joint infection.
Manufacturer:
Zhuhai UNITED Laboratories Co., Ltd.
Related Ingredients